Having options can lower vaccine hesitancy, finds research
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
COVID-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with SARS-CoV-2 infection were clear: individuals with severe cases of COVID-19 often died from cardiovascular ...
Mar 26, 2024
0
1
Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids, like fentanyl and heroin, as well as cocaine—leading ...
Apr 3, 2024
0
42
Africa's most populous nation Nigeria has launched a "revolutionary" vaccine against meningitis, in what the World Health Organization (WHO) on Friday said was a world first.
Apr 13, 2024
0
0
European researchers are pioneering a vaccine and treatment for amyotrophic lateral sclerosis.
Apr 19, 2024
0
11
From spring break parties to Mardi Gras, many people remember the last major "normal" thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.
Apr 4, 2024
0
4
Africa is experiencing unprecedented growth in terms of both population and economic transformation.
Apr 16, 2024
0
0
An analysis of data from a nationwide health survey reveals "concerning" disparities in human papillomavirus (HPV) vaccine uptake among US adults aged 27 to 45 years.
Mar 28, 2024
0
14
Women who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected.
Apr 12, 2024
0
0
Canada is seeing a resurgence of measles, with cases in the first quarter of 2024 already far surpassing the total for all of 2023. There were 12 cases last year, and more than three times that number so far in 2024, with ...
Mar 24, 2024
0
0